ReviewTherapeutic advances in hematology2019

Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program.

Toshko Lissitchkov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.